Filing Details

Accession Number:
0001415889-24-027656
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-25 17:53:03
Reporting Period:
2024-11-22
Accepted Time:
2024-11-25 17:53:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1826667 Trisalus Life Sciences Inc. TLSI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1459154 Mats Wahlstrom 6272 W. 91St Avenue
Westminster CO 80031
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-22 5,000 $4.55 15,727 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,254,259 Indirect By Leonard Capital LLC
Common Stock 1,370,028 Indirect By HW Investment Partners, LLC
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.45 to $4.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  2. The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC.
  3. The Reporting Person is a managing member of HW Investment Partners, LLC ("HW Investment") and shares voting and investment discretion with respect to the shares held directly by HW Investment. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.